Inflammation & Autoimmune: Experience & Expertise
- AUTOIMMUNE and INFLAMMATORY DISEASE is another active area of research for Defined Health. Our experience in this indication touches on all three of our main business activities and includes performing opportunity assessments of specific products, identifying licensing and acquisition opportunities in search projects, and strategic projects focused on prioritizing lead and follow-on indications for products with broad mechanisms that are applicable to multiple indications across physician specialties.
- The AIID franchise is led by Defined Health Vice President, Aileen Nicoletti, PhD.
- Defined Health has developed a strategic framework for evaluating novel compounds and mechanisms in the AIID space based on scientific, clinical, and commercial attributes that are carefully refined based on the strategic goals and risk tolerance of our clients. Many of our projects in this area focus on utilizing this approach to prioritize indications for clinical development.
- Recent target indications include Rheumatoid Arthritis, Multiple Sclerosis, Systemic Lupus, Lupus Nephritis, Psoriasis, Ankylosing Spondylitis, Sjogren’s Syndrome, Myasthenia Gravis, and many others.